We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+19.23%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.08B
AUM Growth
+$128M
Cap. Flow
-$13.4M
Cap. Flow %
-1.24%
Top 10 Hldgs %
65.89%
Holding
283
New
55
Increased
41
Reduced
42
Closed
144

Top Buys

Rank Stock Value
1
AQST icon
Aquestive Therapeutics
AQST
+$190M
2
PGRE
Paramount Group
PGRE
+$8.09M
3
O icon
Realty Income
O
+$7.08M
4
HST icon
Host Hotels & Resorts
HST
+$6.74M
5
AVGO icon
Broadcom
AVGO
+$6.66M

Top Sells

Rank Stock Value
1
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$11.1M
2
AMG icon
Affiliated Managers Group
AMG
+$11M
3
INFO
IHS Markit Ltd. Common Shares
INFO
+$10.3M
4
JEF icon
Jefferies Financial Group
JEF
+$9.88M
5
SEIC icon
SEI Investments
SEIC
+$9.45M

Sector Composition

Rank Sector Weight
1 Healthcare 60.27%
2 Real Estate 10.75%
3 Technology 10.08%
4 Industrials 8.07%
5 Consumer Discretionary 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
151
American Express
AXP
$227B
– –
-51,501
Closed -$5.05M
AZN icon
152
AstraZeneca
AZN
$263B
– –
-77,145
Closed -$5.42M
BAX icon
153
Baxter International
BAX
$13.5B
– –
-52,154
Closed -$3.85M
BCE icon
154
BCE
BCE
$20.2B
– –
-70,000
Closed -$2.83M
BFH icon
155
Bread Financial
BFH
$4.37B
– –
-18,795
Closed -$3.5M
BHF icon
156
Brighthouse Financial
BHF
$3.56B
– –
-52,351
Closed -$2.1M
BHR
157
Braemar Hotels & Resorts
BHR
$156M
– –
-62,108
Closed -$702K
BLUE
158
DELISTED
bluebird bio
BLUE
– –
-1,251
Closed -$2.54M
BMY icon
159
Bristol-Myers Squibb
BMY
$133B
– –
-64,224
Closed -$3.55M
BPMC
160
DELISTED
Blueprint Medicines
BPMC
– –
-26,979
Closed -$1.71M
BSX icon
161
Boston Scientific
BSX
$69.5B
– –
-105,950
Closed -$3.46M
CAG icon
162
Conagra Brands
CAG
$6.94B
– –
-25,175
Closed -$900K
CDP icon
163
COPT Defense Properties
CDP
$4.3B
– –
-28,927
Closed -$839K
CHKP icon
164
Check Point Software Technologies
CHKP
$13B
– –
-23,000
Closed -$2.25M
CLSD
165
DELISTED
Clearside Biomedical
CLSD
– –
-8,443
Closed -$1.35M
CNO icon
166
CNO Financial Group
CNO
$5.14B
– –
-134,374
Closed -$2.56M
CPRX
167
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-488,243
Closed -$1.52M
CSL icon
168
Carlisle Companies
CSL
$14.6B
– –
-18,187
Closed -$1.97M
CZR icon
169
Caesars Entertainment
CZR
$6.06B
– –
-70,760
Closed -$2.77M
DAL icon
170
Delta Air Lines
DAL
$57.5B
– –
-39,898
Closed -$1.98M
DLTR icon
171
Dollar Tree
DLTR
$24.4B
– –
-25,982
Closed -$2.21M
DOC icon
172
Healthpeak Properties
DOC
$15.1B
– –
-113,053
Closed -$2.92M
EPRT icon
173
Essential Properties Realty Trust
EPRT
$6.77B
– –
-186,367
Closed -$2.52M
EQH icon
174
Equitable Holdings
EQH
$13B
– –
-241,980
Closed -$4.99M
ESPR
175
DELISTED
Esperion Therapeutics
ESPR
– –
-44,224
Closed -$1.73M
5 6
7
8 9

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q3 2018 Portfolio in Review

As of Q3 2018, Crestline Management held 283 positions worth $1.08B, up 13% from $952M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Crestline Management's Q3 2018 filing shows 55 new, 41 increased, 42 reduced and 144 closed positions. Its largest new stake was Aquestive Therapeutics: 11,503,294 shares worth $201M. The largest sale was Athene Holding Ltd. Class A Common Shares, an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 43% a quarter earlier, followed by Real Estate and Technology.

  • Crestline Management's largest Q3 2018 buy was Aquestive Therapeutics: 11,503,294 shares worth $201M.
  • Crestline Management added most to Red Hat Inc in Q3 2018, an estimated $6.11M increase.
  • Crestline Management's biggest Q3 2018 reduction was Norwegian Cruise Line, cutting an estimated $4.27M.
  • Crestline Management fully exited Athene Holding Ltd. Class A Common Shares in Q3 2018, selling an estimated $11.1M.
  • Crestline Management's ten largest holdings make up 66% of its $1.08B portfolio in Q3 2018.
  • Crestline Management opened 55 new positions and closed 144 in Q3 2018.
  • Crestline Management's portfolio value rose 13% quarter-over-quarter to $1.08B.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.